DERMATOLOGÍA PRÁCTICA
Omalizumab en el tratamiento de la urticaria crónica inducible
Omalizumab in the Treatment of Chronic Inducible Urticaria
P. Chicharro
, P. Rodríguez, D. de Argila
Autor para correspondencia
Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, España
Leído
15933
Vecesse ha leído el artículo
3478
Total PDF
12455
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 101 | 52 | 153 |
| 2025 5 | 246 | 50 | 296 |
| 2025 4 | 222 | 41 | 263 |
| 2025 3 | 243 | 23 | 266 |
| 2025 2 | 345 | 31 | 376 |
| 2025 1 | 187 | 19 | 206 |
| 2024 12 | 217 | 36 | 253 |
| 2024 11 | 255 | 62 | 317 |
| 2024 10 | 176 | 42 | 218 |
| 2024 9 | 261 | 32 | 293 |
| 2024 8 | 286 | 63 | 349 |
| 2024 7 | 310 | 31 | 341 |
| 2024 6 | 294 | 37 | 331 |
| 2024 5 | 246 | 38 | 284 |
| 2024 4 | 214 | 48 | 262 |
| 2024 3 | 253 | 42 | 295 |
| 2024 2 | 215 | 34 | 249 |
| 2024 1 | 248 | 27 | 275 |
| 2023 12 | 240 | 16 | 256 |
| 2023 11 | 233 | 55 | 288 |
| 2023 10 | 225 | 45 | 270 |
| 2023 9 | 159 | 39 | 198 |
| 2023 8 | 174 | 28 | 202 |
| 2023 7 | 153 | 64 | 217 |
| 2023 6 | 146 | 36 | 182 |
| 2023 5 | 281 | 31 | 312 |
| 2023 4 | 168 | 34 | 202 |
| 2023 3 | 163 | 46 | 209 |
| 2023 2 | 173 | 54 | 227 |
| 2022 1 | 149 | 38 | 187 |
| 2022 12 | 174 | 44 | 218 |
| 2022 11 | 183 | 62 | 245 |
| 2022 10 | 198 | 72 | 270 |
| 2022 9 | 182 | 58 | 240 |
| 2022 8 | 155 | 65 | 220 |
| 2022 7 | 141 | 63 | 204 |
| 2022 6 | 196 | 56 | 252 |
| 2022 5 | 207 | 63 | 270 |
| 2022 4 | 253 | 69 | 322 |
| 2022 3 | 302 | 81 | 383 |
| 2022 2 | 249 | 70 | 319 |
| 2021 1 | 261 | 89 | 350 |
| 2021 12 | 182 | 74 | 256 |
| 2021 11 | 206 | 57 | 263 |
| 2021 10 | 133 | 93 | 226 |
| 2021 9 | 116 | 66 | 182 |
| 2021 8 | 84 | 51 | 135 |
| 2021 7 | 109 | 49 | 158 |
| 2021 6 | 121 | 71 | 192 |
| 2021 5 | 130 | 94 | 224 |
| 2021 4 | 233 | 144 | 377 |
| 2021 3 | 179 | 84 | 263 |
| 2021 2 | 128 | 71 | 199 |
| 2020 1 | 119 | 52 | 171 |
| 2020 12 | 112 | 48 | 160 |
| 2020 11 | 125 | 53 | 178 |
| 2020 10 | 123 | 46 | 169 |
| 2020 9 | 123 | 40 | 163 |
| 2020 8 | 116 | 37 | 153 |
| 2020 7 | 105 | 28 | 133 |
| 2020 6 | 103 | 51 | 154 |
| 2020 5 | 90 | 31 | 121 |
| 2020 4 | 85 | 45 | 130 |
| 2020 3 | 65 | 20 | 85 |
| 2020 2 | 19 | 4 | 23 |
| 2020 1 | 7 | 4 | 11 |
| 2019 12 | 5 | 2 | 7 |
| 2019 11 | 14 | 6 | 20 |
| 2019 10 | 4 | 5 | 9 |
| 2019 9 | 7 | 1 | 8 |
| 2019 8 | 8 | 4 | 12 |
| 2019 7 | 52 | 4 | 56 |
| 2019 6 | 21 | 0 | 21 |
| 2019 5 | 7 | 5 | 12 |
| 2019 4 | 5 | 4 | 9 |
| 2019 3 | 19 | 4 | 23 |
| 2019 2 | 39 | 4 | 43 |
| 2019 1 | 12 | 4 | 16 |
| 2018 12 | 2 | 0 | 2 |
| 2018 11 | 18 | 8 | 26 |
| 2018 10 | 7 | 3 | 10 |
| 2018 9 | 8 | 2 | 10 |
| 2018 7 | 2 | 4 | 6 |
| 2018 6 | 5 | 2 | 7 |
| 2018 5 | 6 | 2 | 8 |
| 2018 4 | 2 | 3 | 5 |
| 2018 3 | 0 | 2 | 2 |
| 2018 2 | 50 | 5 | 55 |
| 2018 1 | 69 | 3 | 72 |
| 2017 12 | 57 | 2 | 59 |
| 2017 11 | 23 | 6 | 29 |
| 2017 10 | 24 | 1 | 25 |
| 2017 9 | 18 | 2 | 20 |
| 2017 8 | 10 | 5 | 15 |
| 2017 7 | 25 | 6 | 31 |
| 2017 6 | 39 | 27 | 66 |
| 2017 5 | 0 | 10 | 10 |
| 2017 4 | 0 | 8 | 8 |
| 2017 3 | 0 | 7 | 7 |
| 2017 2 | 0 | 4 | 4 |
| 2016 1 | 0 | 6 | 6 |
| 2016 12 | 0 | 5 | 5 |
| 2016 11 | 0 | 3 | 3 |
| 2016 10 | 0 | 10 | 10 |
Mostrar todo
